Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Oct:131:103243.
doi: 10.1016/j.fgb.2019.103243. Epub 2019 Jun 20.

Candida auris and multidrug resistance: Defining the new normal

Shawn R Lockhart  1
Affiliations
Review

Candida auris and multidrug resistance: Defining the new normal

Shawn R Lockhart. Fungal Genet Biol. 2019 Oct.

Abstract

Candida auris is an emerging species of yeast characterized by colonization of skin, persistence in the healthcare environment, and antifungal resistance. C. auris was first described in 2009 from a single isolate but has since been reported in more than 25 countries worldwide. Resistance to fluconazole and amphotericin B is common, and resistance to the echinocandins is emerging in some countries. Antifungal resistance has been shown to be acquired rather than intrinsic and the primary mechanisms of resistance to the echinocandins and azoles have been determined. There are a number of new antifungal agents in phase 2 and phase 3 clinical trials and many have activity against C. auris. This review will discuss what is currently known about antifungal resistance in C. auris, limitations to antifungal susceptibility testing, the mechanisms of resistance, and the new antifungals that are on the horizon.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest

None.

References

    1. Abastabar M, et al., 2019. Candida auris otomycosis in Iran and review of recent literature. Mycoses 62, 101–105. - PubMed
    1. Adams E, et al., 2018. Candida auris in healthcare facilities, New York, USA, 2013–2017. Emerg. Infect. Dis. 24, 1816–1824. - PMC - PubMed
    1. Ahmad A, et al., 2019. A high-throughput and rapid method for accurate identification of emerging multidrug-resistant Candida auris. Mycoses 62, 513–518. - PMC - PubMed
    1. Arauz AB, et al., 2018. Isolation of Candida auris from 9 patients in Central America: importance of accurate diagnosis and susceptibility testing. Mycoses 61, 44–47. - PubMed
    1. Arendrup MC, et al., 2018. APX001A in vitro activity against contemporary blood isolates and Candida auris determined by the EUCAST reference method. Antimicrob. Agents Chemother. 62, e01225–e1318. - PMC - PubMed

MeSH terms

LinkOut - more resources